Gene-environment Interactions in Parkinson's Disease: the Importance of Animal Modeling

Overview

Journal Clin Pharmacol Ther

Publisher Wiley

Specialty Pharmacology

Date 2010 Sep 3

PMID 20811350

Citations 40

Authors

M P Horowitz

J T Greenamyre

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD), a late-onset neurodegenerative disorder, occurs most commonly in a "sporadic" (idiopathic) form, without a clearly defined genetic basis and only a vaguely delineated pathogenesis. Together, the various monogenic forms of PD (i.e., those arising from mutations in single genes) account for a minority of PD cases but have provided crucial insights into disease mechanisms. Although it is commonly believed that sporadic PD is caused by a lifetime of environmental exposures that are superimposed on an individual's composite genetic susceptibility, this hypothesis has not been tested adequately. This article reviews genetic and environmental factors that have been associated with PD and attempts to put these into a pathogenic framework. We argue that animal modeling will become increasingly important in attempting to elucidate gene-environment interactions, to define pathogenic mechanisms, and to provide a platform for testing of targeted therapeutic interventions.

Citing Articles

The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson's Disease.

He Q, Zhang S, Wang J, Ma T, Ma D, Wu L Mol Neurobiol. 2024; 61(9):7046-7065.

PMID: 38367134 DOI: 10.1007/s12035-024-04020-y.

Pursuing Multiple Biomarkers for Early Idiopathic Parkinson's Disease Diagnosis.

Gopar-Cuevas Y, Duarte-Jurado A, Diaz-Perez R, Saucedo-Cardenas O, Loera-Arias M, Montes-de-Oca-Luna R Mol Neurobiol. 2021; 58(11):5517-5532.

PMID: 34350555 DOI: 10.1007/s12035-021-02500-z.

Improvement of Oxidative Stress and Mitochondrial Dysfunction by -Caryophyllene: A Focus on the Nervous System.

Ullah H, Di Minno A, Santarcangelo C, Khan H, Daglia M Antioxidants (Basel). 2021; 10(4).

PMID: 33915950 PMC: 8066981. DOI: 10.3390/antiox10040546.

Interdependence of metals and its binding proteins in Parkinson's disease for diagnosis.

Anirudhan A, Prabu P, Sanyal J, Banerjee T, Guha G, Murugesan R NPJ Parkinsons Dis. 2021; 7(1):3.

PMID: 33398051 PMC: 7782529. DOI: 10.1038/s41531-020-00146-7.

Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.

Marotta N, Kim S, Krainc D Expert Opin Drug Discov. 2020; 15(4):427-441.

PMID: 31899983 PMC: 7065944. DOI: 10.1080/17460441.2020.1703671.

References

Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

Kahle P, Neumann M, Ozmen L, Haid S, Okochi M, Haass C . Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice. J Neurochem. 2001; 77(4):1181-4. DOI: 10.1046/j.1471-4159.2001.00366.x. View

Miller D, Hague S, Clarimon J, Baptista M, Gwinn-Hardy K, Cookson M . Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology. 2004; 62(10):1835-8. DOI: 10.1212/01.wnl.0000127517.33208.f4. View

Song D, Shults C, Sisk A, Rockenstein E, Masliah E . Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol. 2004; 186(2):158-72. DOI: 10.1016/S0014-4886(03)00342-X. View

Casarejos M, Menendez J, Solano R, Rodriguez-Navarro J, Garcia de Yebenes J, Mena M . Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. J Neurochem. 2006; 97(4):934-46. DOI: 10.1111/j.1471-4159.2006.03777.x. View

Park J, Lee S, Lee S, Kim Y, Song S, Kim S . Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature. 2006; 441(7097):1157-61. DOI: 10.1038/nature04788. View

Priyadarshi A, Khuder S, Schaub E, Shrivastava S . A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology. 2000; 21(4):435-40. View

Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S . Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998; 392(6676):605-8. DOI: 10.1038/33416. View

Manning-Bog A, Caudle W, Perez X, Reaney S, Paletzki R, Isla M . Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter. Neurobiol Dis. 2007; 27(2):141-50. DOI: 10.1016/j.nbd.2007.03.014. View

10.

Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B . Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol. 2009; 169(8):919-26. PMC: 2727231. DOI: 10.1093/aje/kwp006. View

11.

Manning-Bog A, McCormack A, Purisai M, Bolin L, Di Monte D . Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J Neurosci. 2003; 23(8):3095-9. PMC: 6742319. View

12.

Bonifati V, Rizzu P, van Baren M, Schaap O, Breedveld G, Krieger E . Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2002; 299(5604):256-9. DOI: 10.1126/science.1077209. View

13.

Nieto M, Gil-Bea F, Dalfo E, Cuadrado M, Cabodevilla F, Sanchez B . Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice. Neurobiol Aging. 2005; 27(6):848-56. DOI: 10.1016/j.neurobiolaging.2005.04.010. View

14.

Lesage S, Brice A . Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet. 2009; 18(R1):R48-59. DOI: 10.1093/hmg/ddp012. View

15.

Gash D, Rutland K, Hudson N, Sullivan P, Bing G, Cass W . Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol. 2007; 63(2):184-92. DOI: 10.1002/ana.21288. View

16.

Singleton A, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J . alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003; 302(5646):841. DOI: 10.1126/science.1090278. View

17.

Kim R, Smith P, Aleyasin H, Hayley S, Mount M, Pownall S . Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A. 2005; 102(14):5215-20. PMC: 555037. DOI: 10.1073/pnas.0501282102. View

18.

Manning-Bog A, McCormack A, Li J, Uversky V, Fink A, Di Monte D . The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem. 2001; 277(3):1641-4. DOI: 10.1074/jbc.C100560200. View

19.

Kamel F, Tanner C, Umbach D, Hoppin J, Alavanja M, Blair A . Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am J Epidemiol. 2006; 165(4):364-74. DOI: 10.1093/aje/kwk024. View

20.

Li Y, Liu W, Oo T, Wang L, Tang Y, Jackson-Lewis V . Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci. 2009; 12(7):826-8. PMC: 2845930. DOI: 10.1038/nn.2349. View